Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) advises that all resolutions put to the company’s annual shareholders’ meeting held in Auckland today were passed. The six resolutions were:
Resolution 1: To elect Donal O’Dwyer as a Director.
Resolution 2: To elect Geraldine McBride as a Director.
Resolution 3: To authorise the Directors to fix the fees and expenses of the Company’s auditor.
Resolution 4: To approve the issue of share rights to Michael Daniell as set out in the Notice of Annual Shareholders’ Meeting 2013.
Resolution 5: To approve the issue of options to Michael Daniell as set out in the Notice of Annual Shareholders’ Meeting 2013.
Resolution 6: To approve the Fisher & Paykel Healthcare (North America) Share Option Plan and the Fisher & Paykel Healthcare Performance Share Rights Plan.
All resolutions were decided by poll. The details of the total number of votes cast in person or by proxy on the polls were as follows:
Announcement regarding Directors
Gary Paykel and Nigel Evans retired from the board at the company’s 2013 annual shareholders’ meeting. The Board has appointed Lindsay Gillanders to the company’s Audit & Risk Committee to fill the vacancy left following the retirement of Nigel Evans.
Consequently, the Board has appointed Geraldine McBride to the company’s Remuneration and Human Resources Committee to replace Lindsay Gillanders who will be stepping down from the Remuneration and Human Resources Committee to take up the appointment to the company’s Audit & Risk Committee.
Independence of Directors
In accordance with NZX Listing Rule 3.3.3(a), the Board has determined that Tony Carter, Nigel Evans, Roger France, Lindsay Gillanders, Geraldine McBride, Arthur Morris and Donal O’Dwyer are independent directors.
The factors that the Board considers in assessing the independence of directors are set out in the Board Charter, which can be viewed on the company’s website: www.fphcare.com.
Contact: Tony Barclay, Company Secretary on +64 9 574 0119. For more information about the company visit our website www.fphcare.com
Annual Shareholder's Meeting Results, Director Announcements and Director Independence
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
This access is intended for health professionals only and by accessing it you agree to be a health professional.
I am a health professional. P>
Remember my choice